TY - JOUR
T1 - Microwave-assisted synthesis of N-alkylated bibenzoimidazolyl derivatives
T2 - Antimicrobial studies
AU - Nanjunda Swamy, S.
AU - Kavitha, C. V.
AU - Priya, B. S.
AU - Gaonkar, S. L.
AU - Tejesvi, M. V.
AU - Rangappa, K. S.
PY - 2009/7
Y1 - 2009/7
N2 - The purpose of this study was to evaluate the efficacy of newly synthesized bibenzoimidazolyl derivatives 2(ai) as antimicrobials. These molecules are obtained by the reaction of different pharmaceutically important bioactive aralkyl halides with 1, 7́-dimethyl-2'-propyl-1H, 3'H-[2, 5́]bibenzoimidazole in presence of powdered potassium carbonate in DMF solvent under both conventional and microwave methods. The microwave method offers the products 2(a-i) in higher yields compared to conventional method. All the synthesized compounds were characterized by IR, 1H NMR and elemental analysis and evaluated their efficacy as antimicrobials. We observed the significant differences between the antimicrobial activities of the newly synthesized compounds based on their various substituents present at N1 position. Compounds 2h, 2a, 2c, 2e and 2f showed potent antimicrobial activity compared to standard drugs.
AB - The purpose of this study was to evaluate the efficacy of newly synthesized bibenzoimidazolyl derivatives 2(ai) as antimicrobials. These molecules are obtained by the reaction of different pharmaceutically important bioactive aralkyl halides with 1, 7́-dimethyl-2'-propyl-1H, 3'H-[2, 5́]bibenzoimidazole in presence of powdered potassium carbonate in DMF solvent under both conventional and microwave methods. The microwave method offers the products 2(a-i) in higher yields compared to conventional method. All the synthesized compounds were characterized by IR, 1H NMR and elemental analysis and evaluated their efficacy as antimicrobials. We observed the significant differences between the antimicrobial activities of the newly synthesized compounds based on their various substituents present at N1 position. Compounds 2h, 2a, 2c, 2e and 2f showed potent antimicrobial activity compared to standard drugs.
UR - http://www.scopus.com/inward/record.url?scp=67650513802&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650513802&partnerID=8YFLogxK
U2 - 10.2174/157018009788681083
DO - 10.2174/157018009788681083
M3 - Article
AN - SCOPUS:67650513802
SN - 1570-1808
VL - 6
SP - 380
EP - 386
JO - Letters in Drug Design and Discovery
JF - Letters in Drug Design and Discovery
IS - 5
ER -